• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

b-AP15对20S蛋白酶体的抑制作用。

Inhibitory effect of b-AP15 on the 20S proteasome.

作者信息

Huang Li, Jung Katherine, Chen Chin Ho

机构信息

Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Biomolecules. 2014 Oct 14;4(4):931-9. doi: 10.3390/biom4040931.

DOI:10.3390/biom4040931
PMID:25317846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4279163/
Abstract

The 26S proteasome is a cellular proteolytic complex containing 19S regulatory particles and the 20S core proteasome. It was reported that the small molecule b-AP15 targets the proteasome by inhibiting deubiquitination of the 19S regulatory particles of the proteasome complex. An investigation of b-AP15 on the 20S proteasome core suggested that this compound can also inhibit the 20S proteasome with a potency equivalent to that found to inhibit the 19S regulatory particles.

摘要

26S蛋白酶体是一种细胞内的蛋白水解复合物,包含19S调节颗粒和20S核心蛋白酶体。据报道,小分子b-AP15通过抑制蛋白酶体复合物19S调节颗粒的去泛素化作用来靶向蛋白酶体。对b-AP15作用于20S蛋白酶体核心的研究表明,该化合物还能抑制20S蛋白酶体,其效力与抑制19S调节颗粒时相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/177fecfc60e9/biomolecules-04-00931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/1a2c238ccbcf/biomolecules-04-00931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/2c0d33f0432a/biomolecules-04-00931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/2c74f1069ea5/biomolecules-04-00931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/177fecfc60e9/biomolecules-04-00931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/1a2c238ccbcf/biomolecules-04-00931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/2c0d33f0432a/biomolecules-04-00931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/2c74f1069ea5/biomolecules-04-00931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7485/4279163/177fecfc60e9/biomolecules-04-00931-g004.jpg

相似文献

1
Inhibitory effect of b-AP15 on the 20S proteasome.b-AP15对20S蛋白酶体的抑制作用。
Biomolecules. 2014 Oct 14;4(4):931-9. doi: 10.3390/biom4040931.
2
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.抑制蛋白酶体去泛素化活性作为一种新的癌症治疗方法。
Nat Med. 2011 Nov 6;17(12):1636-40. doi: 10.1038/nm.2536.
3
Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.对去泛素化酶USP14和UCHL5的靶向抑制可诱导华氏巨球蛋白血症肿瘤细胞中的蛋白毒性应激和细胞凋亡。
Br J Haematol. 2015 May;169(3):377-90. doi: 10.1111/bjh.13304. Epub 2015 Feb 17.
4
The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells.去泛素化酶抑制剂 b-AP15 及其对单核细胞来源树突状细胞表型和功能的影响。
Neoplasia. 2019 Jul;21(7):653-664. doi: 10.1016/j.neo.2019.03.001. Epub 2019 May 25.
5
The role of 19S proteasome associated deubiquitinases in activity-dependent hippocampal synaptic plasticity.19S 蛋白酶体相关去泛素化酶在活性依赖的海马突触可塑性中的作用。
Neuropharmacology. 2018 May 1;133:354-365. doi: 10.1016/j.neuropharm.2018.01.043. Epub 2018 Jan 31.
6
Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress.蛋白酶体去泛素化酶抑制剂诱导肿瘤细胞凋亡与氧化应激有关。
Antioxid Redox Signal. 2014 Dec 10;21(17):2271-85. doi: 10.1089/ars.2013.5322. Epub 2013 Oct 17.
7
The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.去泛素化酶抑制剂 b-AP15 诱导强烈的蛋白毒性应激和线粒体损伤。
Biochem Pharmacol. 2018 Oct;156:291-301. doi: 10.1016/j.bcp.2018.08.039. Epub 2018 Aug 25.
8
Deubiquitination by proteasome is coordinated with substrate translocation for proteolysis in vivo.蛋白酶体的去泛素化作用与体内蛋白质水解的底物转运相协调。
Exp Cell Res. 2005 Jul 15;307(2):436-51. doi: 10.1016/j.yexcr.2005.03.031.
9
The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.19S去泛素化酶抑制剂b-AP15在细胞中富集并引发细胞迅速走向死亡。
Mol Pharmacol. 2014 Jun;85(6):932-45. doi: 10.1124/mol.113.091322. Epub 2014 Apr 8.
10
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.一种新型蛋白酶体去泛素化活性抑制剂可使肿瘤细胞对自然杀伤细胞和 T 细胞介导的 TRAIL 凋亡敏感。
Cancer Immunol Immunother. 2013 Aug;62(8):1359-68. doi: 10.1007/s00262-013-1439-1. Epub 2013 May 21.

引用本文的文献

1
A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.一类环境毒素和内源性毒素可导致BRCA2单倍体不足及基因组不稳定。
Cell. 2017 Jun 1;169(6):1105-1118.e15. doi: 10.1016/j.cell.2017.05.010.

本文引用的文献

1
The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.19S去泛素化酶抑制剂b-AP15在细胞中富集并引发细胞迅速走向死亡。
Mol Pharmacol. 2014 Jun;85(6):932-45. doi: 10.1124/mol.113.091322. Epub 2014 Apr 8.
2
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.一种新型小分子去泛素化酶 USP14 和UCHL5 的抑制剂诱导多发性骨髓瘤细胞凋亡并克服硼替佐米耐药。
Blood. 2014 Jan 30;123(5):706-16. doi: 10.1182/blood-2013-05-500033. Epub 2013 Dec 6.
3
Structural biology of the proteasome.
蛋白酶体的结构生物学。
Annu Rev Biophys. 2013;42:29-49. doi: 10.1146/annurev-biophys-083012-130417. Epub 2013 Feb 13.
4
Applied techniques for mining natural proteasome inhibitors.天然蛋白酶体抑制剂的挖掘应用技术。
Biochim Biophys Acta. 2014 Jan;1843(1):26-38. doi: 10.1016/j.bbamcr.2013.01.017. Epub 2013 Jan 27.
5
Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators.作为蛋白酶体调节剂的石胆酸衍生物的合成
ACS Med Chem Lett. 2012;3(11):925-930. doi: 10.1021/ml3001962. Epub 2012 Aug 15.
6
New proteasome inhibitors in myeloma.多发性骨髓瘤的新型蛋白酶体抑制剂。
Curr Hematol Malig Rep. 2012 Dec;7(4):258-66. doi: 10.1007/s11899-012-0141-2.
7
Proteasome inhibitors: an expanding army attacking a unique target.蛋白酶体抑制剂:一支不断壮大的攻击独特靶点的队伍。
Chem Biol. 2012 Jan 27;19(1):99-115. doi: 10.1016/j.chembiol.2012.01.003.
8
Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.家族性阿尔茨海默病动物模型中随着疾病进展的淀粉样生成和免疫蛋白酶体功能障碍激活。
Brain Pathol. 2012 Sep;22(5):636-53. doi: 10.1111/j.1750-3639.2011.00560.x. Epub 2012 Jan 13.
9
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.抑制蛋白酶体去泛素化活性作为一种新的癌症治疗方法。
Nat Med. 2011 Nov 6;17(12):1636-40. doi: 10.1038/nm.2536.
10
Exploiting nature's rich source of proteasome inhibitors as starting points in drug development.利用天然丰富的蛋白酶体抑制剂作为药物开发的起点。
Chem Commun (Camb). 2012 Feb 1;48(10):1364-78. doi: 10.1039/c1cc15273d. Epub 2011 Oct 31.